Ledger.Open graph →
SEC Form D · filed November 2, 2018

Rekindle Therapeutics Inc

Offering
$6.5M
Sold
$1.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Ed Hurwitz · Cambridge, MADirectorBard Geesaman · Brisbane, CADirectorDetlev Biniszkiewicz · Cambridge, MAExec · DirectorDetlev Biniszkiewicz · Cambridge, MAExec · DirectorEd Hurwitz · South San Francisco, CADirectorBard Geesaman · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗